CLASS ACTION UPDATE for EHTH, FITB and CTMX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Back to Newsroom
Mentioned in this Article

CLASS ACTION UPDATE for EHTH, FITB and CTMX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Thursday, May 28, 2020 3:50 PM
Share this article now
Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / May 28, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

EHTH Shareholders Click Here: https://www.zlk.com/pslra-1/ehealth-inc-loss-form?prid=6980&wire=1
FITB Shareholders Click Here: https://www.zlk.com/pslra-1/fifth-third-bancorp-loss-form?prid=6980&wire=1
CTMX Shareholders Click Here: https://www.zlk.com/pslra-1/cytomx-therapeutics-inc-loss-submission-form?prid=6980&wire=1

* ADDITIONAL INFORMATION BELOW *

eHealth, Inc. (NASDAQ:EHTH)

EHTH Lawsuit on behalf of: investors who purchased March 19, 2018 - April 7, 2020
Lead Plaintiff Deadline: June 8, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/ehealth-inc-loss-form?prid=6980&wire=1

The complaint alleges that eHealth, Inc. issued materially false and/or misleading information and/or failed to disclose: (1) its highly aggressive accounting and modeling assumptions; (2) its skyrocketing rate of member churn, resulting from eHealth's pursuit of low quality, lossmaking growth; (3) its reliance on direct response television advertising, which attracts an unprofitable, high churn enrollee; and (4) that as a result of the foregoing, defendants' public statements were materially false and misleading at all relevant times.

Fifth Third Bancorp (NASDAQ:FITB)

FITB Lawsuit on behalf of: investors who purchased February 26, 2016 - March 6, 2020
Lead Plaintiff Deadline: June 8, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/fifth-third-bancorp-loss-form?prid=6980&wire=1

According to the filed complaint, during the class period, Fifth Third Bancorp made materially false and/or misleading statements and/or failed to disclose that: (i) as a result of Fifth Third Bank's aggressive incentive policies to promote its cross-sell strategy, Fifth Third Bank employees engaged in unauthorized conduct with customer accounts; (ii) since at least 2008, Fifth Third Bank, and by extension, Fifth Third, was aware of such unauthorized conduct and, thus, that it was violating relevant regulations and laws aimed at protecting its consumers; (iii) Fifth Third failed to properly implement and monitor its cross-sell program, detect and stop misconduct, and identify and remediate harmed consumers; (iv) all the foregoing subjected the Company to a foreseeable risk of heightened regulatory scrutiny or investigation; (v) Fifth Third's revenues were in part the product of unlawful conduct and thus unsustainable; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

CytomX Therapeutics, Inc. (NASDAQ:CTMX)

CTMX Lawsuit on behalf of: investors who purchased May 17, 2018 - May 13, 2020
Lead Plaintiff Deadline: July 20, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/cytomx-therapeutics-inc-loss-submission-form?prid=6980&wire=1

According to the filed complaint, during the class period, CytomX Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) CytomX had downplayed issues with CX-072's efficacy observed in the PROCLAIM-CX-072 clinical program; (ii) CytomX had similarly downplayed issues with CX-2009's efficacy and safety observed in the PROCLAIM-CX-2009 clinical program; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
http://www.zlk.com

SOURCE: Levi & Korsinsky, LLP

Levi & Korsinsky, LLP
Back to Newsroom
Copyright 2020 © ACCESSWIRE. All rights reserved. Privacy Policy  |  Terms and Conditions
Drop us a line: